ĀÜĄņĀŅĀ×

Ewa Carrier, M.D. is the Executive Director of Clinical Development for FibroGen, Inc. Previously she held positions as the Director of Clinical Development and Medical Affairs for Boehringer Ingelheim, and as the Vice President of Medical Affairs at NovaRx Corporation, where she was a principal investigator and co-investigator for clinical protocols. Dr. Carrier is a distinguished leader and innovator in the field of cancer diagnosis and treatment. She served as an Associate Professor of Clinical Medicine and Pediatrics in the blood and marrow transplant program at the University of California, San Diego School of Medicine. Dr. Carrier has board certifications in Pediatrics and Pediatric Hematology/Oncology.

Her research is focused on stem cell transplantation, cancer stem cells, and cancer vaccines. Dr. Carrier performed her postdoctoral fellowship at the University of California, San Francisco, a Hematology-Oncology Fellowship at Childrenā€™s Hospital in Oakland, California, and Pediatric Residencies at the Stanford University Medical Center and White Memorial Medical Center at Loma Linda University in Los Angeles. Dr. Carrier received her M.D. with honors from the Wroclaw University School of Medicine in Wroclaw, Poland and has published many high-impact articles in this field.